ConductScience.org, home

Paper23630412

Phentermine and topiramate for the management of obesity: a review.

Cosentino G and 2 others. Drug Des Devel Ther, 2013. Cited by 48 papers, by iCite.

Cite this record

ConductScience Library. Phentermine and topiramate for the management of obesity: a review. Papers, record 23630412. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23630412

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Phentermine and topiramate for the management of obesity: a review.
PubMed
Journal
Drug Des Devel Ther
PubMed
Year
2013
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
48
iCite
Relative citation ratio, by iCite
1.4
iCite
Revised in PubMed
2024-11-26
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Cosentino GGina
2Conrad AOAriane O
3Uwaifo GIGabriel I

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anti-Obesity AgentsMajor topic
FructoseMajor topic
ObesityMajor topic
PhentermineMajor topic
Clinical Trials as Topic
Drug Therapy, Combination
Humans
Topiramate

Source PubMed

Download CSV of topics

References76

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
120806811A case of profound weight loss secondary to use of phentermine.J Miss State Med Assoc2009https://conductscience.org/library/papers/20806811PubMed
21587072Long-term weight control study. I (weeks 0 to 34). The enhancement of behavior modification, caloric restriction, and exercise by fenfluramine plus phentermine versus placebo.Clin Pharmacol Ther1992https://conductscience.org/library/papers/1587072PubMed
322238007A systematic review of the literature concerning the relationship between obesity and mortality in the elderly.J Nutr Health Aging2012https://conductscience.org/library/papers/22238007PubMed
422595709Pediatric obesity.Surg Clin North Am2012https://conductscience.org/library/papers/22595709PubMed
519846734Comparison of combined bupropion and naltrexone therapy for obesity with monotherapy and placebo.J Clin Endocrinol Metab2009https://conductscience.org/library/papers/19846734PubMed
68156972Topiramate: preclinical evaluation of structurally novel anticonvulsant.Epilepsia1994https://conductscience.org/library/papers/8156972PubMed
721807295Polypill and global cardiovascular health strategies.Semin Thorac Cardiovasc Surg2011https://conductscience.org/library/papers/21807295PubMed
822860172ACS chemical neuroscience molecule spotlight on contrave.ACS Chem Neurosci2011https://conductscience.org/library/papers/22860172PubMed
919885278Drugs in the pipeline for the obesity market.J Diabetes Sci Technol2008https://conductscience.org/library/papers/19885278PubMed
1015251779Long-term pharmacologic treatment of morbid obesity in a community practice.Endocr Pract1997https://conductscience.org/library/papers/15251779PubMed
1122439841Anti-obesity drugs: a review about their effects and their safety.Expert Opin Drug Saf2012https://conductscience.org/library/papers/22439841PubMed
1221527891Blood pressure and heart rate effects, weight loss and maintenance during long-term phentermine pharmacotherapy for obesity.Obesity (Silver Spring)2011https://conductscience.org/library/papers/21527891PubMed
1322221216Sarcopenic obesity in the elderly and strategies for weight management.Nutr Rev2012https://conductscience.org/library/papers/22221216PubMed
1421309176[Drug control of appetite].Rev Med Suisse2011https://conductscience.org/library/papers/21309176PubMed
152000046Thermogenic synergism between ephedrine and caffeine in healthy volunteers: a double-blind, placebo-controlled study.Metabolism1991https://conductscience.org/library/papers/2000046PubMed
1622797374Prevalence, pathophysiology, health consequences and treatment options of obesity in the elderly: a guideline.Obes Facts2012https://conductscience.org/library/papers/22797374PubMed
1720707765Phentermine, topiramate and their combination for the treatment of adiposopathy ('sick fat') and metabolic disease.Expert Rev Cardiovasc Ther2010https://conductscience.org/library/papers/20707765PubMed
1822224894The medicalization of chronic disease and costs.Annu Rev Public Health2012https://conductscience.org/library/papers/22224894PubMed
1922778866ACS chemical neuroscience molecule spotlight on Qnexa.ACS Chem Neurosci2011https://conductscience.org/library/papers/22778866PubMed
2010768292An overview of the preclinical aspects of topiramate: pharmacology, pharmacokinetics, and mechanism of action.Epilepsia2000https://conductscience.org/library/papers/10768292PubMed

See all 76 referencesDownload CSV of references

Cited by32

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 48 citations.

PMIDTitleJournalYearIn PapersSource
42452898Amylin Analogs: The Next Major Class of Weight Loss Therapy: A Review of Experimental Data and Early-Phase Clinical Trials.Diabetes Obes Metab2026https://conductscience.org/library/papers/42452898PubMed
42369736Assessing risk of COVID-19 reinfection and complications in adults treated with stimulant medications: A retrospective study using electronic health records.Med Res Arch2024https://conductscience.org/library/papers/42369736PubMed
42158915Voltage-gated potassium channels as important modulators of glucose-stimulated insulin secretion in pancreatic β-cells: insights from rodent and human studies.Front Endocrinol (Lausanne)2026https://conductscience.org/library/papers/42158915PubMed
42010729Role of adipose tissue in cardiovascular health and diseases.Chin Med J (Engl)2026https://conductscience.org/library/papers/42010729PubMed
41973072A Narrative Review of Weight Management Strategies: From Lifestyle Interventions to Emerging Pharmacotherapies.J Obes2026https://conductscience.org/library/papers/41973072PubMed
41484835Bioactive Phytoconstituents Targeting Energy Expenditure and Appetite to Combat Obesity: A Comprehensive Review.Curr Nutr Rep2026https://conductscience.org/library/papers/41484835PubMed
41153573Updates on Anti-Obesity Medications in Children and Adolescents.Children (Basel)2025https://conductscience.org/library/papers/41153573PubMed
40741596Weight Loss With Topiramate and Phentermine Combination Therapy in a Patient With Bardet-Biedl Syndrome.JCEM Case Rep2025https://conductscience.org/library/papers/40741596PubMed
40469756Setting Expectations When Prescribing Medication for the Treatment of Patients With Obesity.Mayo Clin Proc Innov Qual Outcomes2025https://conductscience.org/library/papers/40469756PubMed
39836249Pharmacokinetics and bioequivalence evaluation of two oral formulations of topiramate tablets in healthy Chinese male volunteers under fasting and fed conditions.Naunyn Schmiedebergs Arch Pharmacol2025https://conductscience.org/library/papers/39836249PubMed
39559664Obesity Medications and Their Impact on Cardiovascular Health: A Narrative Review.Cureus2024https://conductscience.org/library/papers/39559664PubMed
38841705Rare Case of Endoscopically Diagnosed Ischemic Colitis Secondary to Chronic Phentermine Use.ACG Case Rep J2024https://conductscience.org/library/papers/38841705PubMed
38664450Surgery is associated with better long-term outcomes than pharmacological treatment for obesity: a systematic review and meta-analysis.Sci Rep2024https://conductscience.org/library/papers/38664450PubMed
38347465Influence of metabolic state and body composition on the action of pharmacological treatment of migraine.J Headache Pain2024https://conductscience.org/library/papers/38347465PubMed
37990741Case report of PLXNA4 variant associated with hyper-response to phentermine/topiramate pharmacotherapy: Potential genetic basis for superior weight loss response?Obes Pillars2023https://conductscience.org/library/papers/37990741PubMed
37576108Visceral adipose tissue and residual cardiovascular risk: a pathological link and new therapeutic options.Front Cardiovasc Med2023https://conductscience.org/library/papers/37576108PubMed
37513906Is There a Risk for Semaglutide Misuse? Focus on the Food and Drug Administration's FDA Adverse Events Reporting System (FAERS) Pharmacovigilance Dataset.Pharmaceuticals (Basel)2023https://conductscience.org/library/papers/37513906PubMed
37349257Approved Anti-Obesity Medications in 2022 KSSO Guidelines and the Promise of Phase 3 Clinical Trials: Anti-Obesity Drugs in the Sky and on the Horizon.J Obes Metab Syndr2023https://conductscience.org/library/papers/37349257PubMed
37139804Pharmacological Treatments and Natural Biocompounds in Weight Management.Pharmaceuticals (Basel)2023https://conductscience.org/library/papers/37139804PubMed
37123787Dilated Cardiomyopathy: Beware of Diet Drugs Slimming the Heart.Cureus2023https://conductscience.org/library/papers/37123787PubMed

See all 32 cited byDownload CSV of cited by

Genes7

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
AQP5362PubTator's text mininghttps://conductscience.org/library/genes/362NCBI Gene
BCHE590PubTator's text mininghttps://conductscience.org/library/genes/590NCBI Gene
CFTR1080PubTator's text mininghttps://conductscience.org/library/genes/1080NCBI Gene
CYP2C191557PubTator's text mininghttps://conductscience.org/library/genes/1557NCBI Gene
CYP3A41576PubTator's text mininghttps://conductscience.org/library/genes/1576NCBI Gene
EREG2069PubTator's text mininghttps://conductscience.org/library/genes/2069NCBI Gene
INS3630PubTator's text mininghttps://conductscience.org/library/genes/3630NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/23630412

GET https://conductscience.org/api/papers/v1/23630412/references?page=2